Insight Wealth Strategies’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.97M Sell
139,664
-3,625
-3% -$143K 0.49% 67
2026
Q2
$7.14M Sell
143,289
-2
-0% -$72 0.7% 42
2026
Q1
$3.51M Buy
143,291
+1,650
+1% +$39.1K 0.39% 83
2025
Q4
$3.51M Buy
+141,641
New +$3.76M 0.4% 80

Other funds holding ASTH

Insight Wealth Strategies's ASTH Position: Q3 2026 in Review

Insight Wealth Strategies reduced its Astrana Health (ASTH) stake by 2.5% in Q3 2026, selling an estimated $143K and leaving 139,664 shares worth $4.97M. The position accounts for 0.49% of the portfolio, ranked #67.

Insight Wealth Strategies first reported a position in ASTH in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.14M in Q2 2026. 11 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Insight Wealth Strategies held 139,664 shares of Astrana Health worth $4.97M as of Q3 2026.
  • Insight Wealth Strategies sold 3,625 Astrana Health shares in Q3 2026, an estimated $143K.
  • Astrana Health made up 0.49% of Insight Wealth Strategies's portfolio in Q3 2026, its #67 holding.
  • Insight Wealth Strategies first reported a position in Astrana Health in Q4 2025 and has held it in 4 quarters since.
  • Insight Wealth Strategies's Astrana Health position peaked at $7.14M in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Insight Wealth Strategies's 13F filing for Q3 2026, filed 9 Oct 2026.